med-mastodon.com is one of the many independent Mastodon servers you can use to participate in the fediverse.
Medical community on Mastodon

Administered by:

Server stats:

344
active users

Manju George MVSc PhD

RT @PanCAN@twitter.com

Q12. @ASCO@twitter.com data 📊 presented from the @IpsenGroup@twitter.com phase III NAPOLI 3 trial, evaluating the NALIRIFOX regimen showed positive results in overall survival for patients with previously untreated metastatic . 💜 pcan.at/2vaeny

🐦🔗: twitter.com/PanCAN/status/1618

PanCANPositive Clinical Trial Results Highlighted at Gastrointestinal Cancers ConferenceBy Allison Rosenzweig, PhD